Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 14, 2012; 18(34): 4629-4634
Published online Sep 14, 2012. doi: 10.3748/wjg.v18.i34.4629
Published online Sep 14, 2012. doi: 10.3748/wjg.v18.i34.4629
miRNAs | Sample type | Population (n) | Approach | Reference |
miRs-192, 375, 422b, 16, 21, 23a, 24, 29a, 126, 195, and let-7f | Sigmoid colon biopsies | Active UC (n = 15) vs healthy controls (n = 15) | Microarray and qRT-PCR | Wu et al[45] |
miR-21 and miR-155 | Sigmoid colon biopsies | Active UC (n = 12) vs healthy controls (n = 12) | Microarray and qRT-PCR | Takagi et al[49] |
miRs-19b, 629, 23b, 106a, and 191 | Sigmoid colon biopsies | Active CD (n = 5) vs healthy controls (n = 13) | Microarray and qRT-PCR | Wu et al[50] |
miRs-16, 21, 223, and 594 | Terminal ileum biopsies | Active CD (n = 6) vs healthy controls (n = 13) | Microarray and qRT-PCR | Wu et al[50] |
miRs-188-5p, 215, 320a, 346, 7, 31, 135b, 223, 29a, 29b, 126*, 127-3p, and 324-3p | Colon biopsies | Active UC (n = 8) vs healthy controls (n = 8) | qRT-PCR | Fasseu et al[51] |
miRs-188-5p, 215, 320a, 346, 196a, 29a, 29b, 126*, 127-3p, and 324-3p | Colon biopsies | Inactive UC (n = 8) vs healthy controls (n = 8) | qRT-PCR | Fasseu et al[51] |
miRs-9, 126, 130a, 181c, 375, 26a, 29b, 30b, 34c-5p, 126*, 127-3p, 133b, 155, 196a, 324-3p, 21, 22, 29c, 31, 106a, 146a, 146b-3p, and 150 | Colon biopsies | Active CD (n = 8) vs healthy controls (n = 8) | qRT-PCR | Fasseu et al[51] |
miRs-9*, 30a*, 30c, 223, 26a, 29b, 30b, 34c-5p, 126*, 127-3p, 133b, 155, 196a, 324-3p, 21, 22, 29c, 31, 106a, 146a, 146b-3p, and 150 | Colon biopsies | Inactive CD (n = 8) vs healthy controls (n = 8) | qRT-PCR | Fasseu et al[51] |
miRs-150, 196b, 199a-3p, 199b-5p, 223, and 320a | Colon biopsies | Inactive UC (n = 8) vs Inactive CD (n = 8) | qRT-PCR | Fasseu et al[51] |
miR-7 | Colon biopsies | Active CD (n = 8) vs healthy controls (n = 6) | qRT-PCR | Nguyen et al[53] |
miR-150 | Colon biopsies | Active UC (n = 5) vs healthy controls (n = 4) | qRT-PCR | Bian et al[47] |
miR-196 | Colon biopsies | Active CD (n = 83) vs healthy controls (n = 67) | qRT-PCR and ISH | Brest et al[54] |
miR-143 and miR-145 | Colon biopsies | Active UC (n = 8) vs healthy controls (n = 8) | qRT-PCR | Pekow et al[52] |
- Citation: Coskun M, Bjerrum JT, Seidelin JB, Nielsen OH. MicroRNAs in inflammatory bowel disease - pathogenesis, diagnostics and therapeutics. World J Gastroenterol 2012; 18(34): 4629-4634
- URL: https://www.wjgnet.com/1007-9327/full/v18/i34/4629.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i34.4629